Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway

Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway

Ovarian cancer (OVCA) patients often develop tolerance to standard platinum therapy that accounts for extensive treatment failures. Cisplatin resistant OVCA cells (cis-R) display enhanced survival mechanisms to cope with therapeutic stress. In these cells, increased autophagy process assists in chem...

Full description

Bibliographic Details
Main Authors: Arpita Kulshrestha, Gajendra K. Katara, Safaa A. Ibrahim, Valerie Riehl, Manoranjan Sahoo, James Dolan, Kyle W. Meinke, Michael R. Pins, Kenneth D. Beaman
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Oncology
Online Access:http://dx.doi.org/10.1155/2019/2343876

Internet

http://dx.doi.org/10.1155/2019/2343876

Similar Items